404 related articles for article (PubMed ID: 29262670)
1. Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression.
Sharma S; Zuñiga F; Rice GE; Perrin LC; Hooper JD; Salomon C
Oncotarget; 2017 Nov; 8(61):104687-104703. PubMed ID: 29262670
[TBL] [Abstract][Full Text] [Related]
2. Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications.
Croft PK; Sharma S; Godbole N; Rice GE; Salomon C
Cells; 2021 Sep; 10(9):. PubMed ID: 34571921
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
4. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
Sharma S; Salomon C
Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in diagnostic and therapeutic applications of ovarian cancer.
Bhavsar D; Raguraman R; Kim D; Ren X; Munshi A; Moore K; Sikavitsas V; Ramesh R
J Ovarian Res; 2024 May; 17(1):113. PubMed ID: 38796525
[TBL] [Abstract][Full Text] [Related]
6. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
7. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200.
Kobayashi M; Salomon C; Tapia J; Illanes SE; Mitchell MD; Rice GE
J Transl Med; 2014 Jan; 12():4. PubMed ID: 24393345
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance.
Vasconcelos MH; Caires HR; Ābols A; Xavier CPR; Linē A
Drug Resist Updat; 2019 Dec; 47():100647. PubMed ID: 31704541
[TBL] [Abstract][Full Text] [Related]
11. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
Li G; Tang W; Yang F
Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
[TBL] [Abstract][Full Text] [Related]
12. Exosomal biomarkers for cancer diagnosis and patient monitoring.
Makler A; Asghar W
Expert Rev Mol Diagn; 2020 Apr; 20(4):387-400. PubMed ID: 32067543
[No Abstract] [Full Text] [Related]
13. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C
Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248
[TBL] [Abstract][Full Text] [Related]
14. The biological significance and clinical applications of exosomes in ovarian cancer.
Dorayappan KDP; Wallbillich JJ; Cohn DE; Selvendiran K
Gynecol Oncol; 2016 Jul; 142(1):199-205. PubMed ID: 27058839
[TBL] [Abstract][Full Text] [Related]
15. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
[TBL] [Abstract][Full Text] [Related]
16. Exosomes: A potential tool for immunotherapy of ovarian cancer.
Gong X; Chi H; Strohmer DF; Teichmann AT; Xia Z; Wang Q
Front Immunol; 2022; 13():1089410. PubMed ID: 36741380
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived exosomes in colorectal cancer progression and their clinical applications.
Zhou J; Li XL; Chen ZR; Chng WJ
Oncotarget; 2017 Nov; 8(59):100781-100790. PubMed ID: 29246022
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro P; Macedo G; Melo SA
Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
[TBL] [Abstract][Full Text] [Related]
20. Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment.
Caruso Bavisotto C; Cappello F; Macario AJL; Conway de Macario E; Logozzi M; Fais S; Campanella C
Expert Rev Mol Diagn; 2017 Sep; 17(9):815-822. PubMed ID: 28718351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
